Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain medical procedures to reduce the risk of clotting.

Aggrastat is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI) or those with unstable angina. It works by inhibiting platelet aggregation, which helps to keep blood flowing smoothly through the arteries. This medication is often used in combination with other anticoagulants to enhance its effectiveness.

Common effects of Aggrastat may include bleeding, bruising, and prolonged bleeding from cuts or injuries. Some patients may also experience nausea, headache, or dizziness. These effects are generally mild and temporary, but any severe or persistent symptoms should be discussed with a healthcare provider.

Aggrastat should be handled with care, as it can increase the risk of bleeding. Patients with a history of bleeding disorders, recent surgery, or severe hypertension should use this medication cautiously. It is important to follow the healthcare provider's instructions and to report any unusual bleeding or bruising immediately.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol and certain supplements may also increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking before starting Aggrastat.